We think, therefore we are; by the way, what are we?

At ChemLaws, we support the individuals and organizations endeavoring to provide answers to this fundamental question. With each passing day, the legal landscape for psychedelic-centric Cognitive Research continues to evolve both domestically and abroad. As universal supporters of medicine and knowledge-based relief, we are committed to contributing to the emergence of meaningful therapies generated from this Cognitive Research. We can assist:

• Law Firms interested in better understanding the history and real-time collapse of the enforceability associated with the Federal Analog Act
• Lobbyists and Legislators aiming to craft meaningful legislation intended to regulate Cognitive Research and access to its derivative therapies
• Universities, Research Institutes and Private Firms seeking to access verified, raw materials associated with Cognitive Research